Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial

  1. Fizazi, K.
  2. González Mella, P.
  3. Castellano, D.
  4. Minatta, J.N.
  5. Rezazadeh Kalebasty, A.
  6. Shaffer, D.
  7. Vázquez Limón, J.C.
  8. Sánchez López, H.M.
  9. Armstrong, A.J.
  10. Horvath, L.
  11. Bastos, D.A.
  12. Amin, N.P.
  13. Li, J.
  14. Unsal-Kacmaz, K.
  15. Retz, M.
  16. Saad, F.
  17. Petrylak, D.P.
  18. Pachynski, R.K.
Aldizkaria:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Argitalpen urtea: 2022

Alea: 160

Orrialdeak: 61-71

Mota: Artikulua

DOI: 10.1016/J.EJCA.2021.09.043 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus